TY - JOUR
T1 - Hospitalization costs for patients with acute congestive heart failure in Japan
AU - Kanaoka, Koshiro
AU - Okayama, Satoshi
AU - Nakai, Michikazu
AU - Sumita, Yoko
AU - Nishimura, Kunihiro
AU - Kawakami, Rika
AU - Okura, Hiroyuki
AU - Miyamoto, Yoshihiro
AU - Yasuda, Satoshi
AU - Tsutsui, Hiroyuki
AU - Komuro, Issei
AU - Ogawa, Hisao
AU - Saito, Yoshihiko
N1 - Funding Information:
The authors thank AMED under Grant no. 17ek0210080h0001.
Publisher Copyright:
© 2019, Japanese Circulation Society. All rights reserved.
PY - 2019
Y1 - 2019
N2 - Background: With aging of the population, the economic burden associated with heart failure (HF) is expected to increase. However, little is known about the hospitalization costs associated with HF in Japan. Methods and Results: In this cross-sectional study, using data from The Japanese Registry of All Cardiac and Vascular Diseases (JROAD) and JROAD-Diagnosis Procedure Combination databases between 2012 and 2014, we evaluated hospitalization costs for acute cardiovascular diseases (CVDs), including HF. A total of $1,187 million/year (44% of the hospitalization costs for acute CVDs) was spent on patients with HF. We identified 273,865 patients with HF and the median cost per patient was $8,089 ($5,362-12,787) per episode. The top 1% of spenders accounted for 8% ($80 million/year), and the top 5% of spenders accounted for 22% ($229 million/year) of the entire cost associated with HF. The costs associated with HF for patients over 75 years of age accounted for 68% of the total cost. Conclusions: The costs associated with HF were higher than the hospitalization cost for any other acute CVD in Japan. Understanding how the total hospitalization cost is distributed may allow health providers to utilize limited resources more effectively for patients with HF.
AB - Background: With aging of the population, the economic burden associated with heart failure (HF) is expected to increase. However, little is known about the hospitalization costs associated with HF in Japan. Methods and Results: In this cross-sectional study, using data from The Japanese Registry of All Cardiac and Vascular Diseases (JROAD) and JROAD-Diagnosis Procedure Combination databases between 2012 and 2014, we evaluated hospitalization costs for acute cardiovascular diseases (CVDs), including HF. A total of $1,187 million/year (44% of the hospitalization costs for acute CVDs) was spent on patients with HF. We identified 273,865 patients with HF and the median cost per patient was $8,089 ($5,362-12,787) per episode. The top 1% of spenders accounted for 8% ($80 million/year), and the top 5% of spenders accounted for 22% ($229 million/year) of the entire cost associated with HF. The costs associated with HF for patients over 75 years of age accounted for 68% of the total cost. Conclusions: The costs associated with HF were higher than the hospitalization cost for any other acute CVD in Japan. Understanding how the total hospitalization cost is distributed may allow health providers to utilize limited resources more effectively for patients with HF.
UR - http://www.scopus.com/inward/record.url?scp=85065218674&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85065218674&partnerID=8YFLogxK
U2 - 10.1253/circj.CJ-18-1212
DO - 10.1253/circj.CJ-18-1212
M3 - Article
C2 - 30918219
AN - SCOPUS:85065218674
SN - 1346-9843
VL - 83
SP - 1025
EP - 1031
JO - Circulation Journal
JF - Circulation Journal
IS - 5
ER -